MRN : ABYREL- Reference No.

: Lab ID : 8645200
6072141199510
Name DOB : 26-10-1986
: SAURABH GHARAT HEMANT GHARAT
Gender Reg. Date : 24-08-2021 08:11:39
: Male
Age Collection Date : 24-08-2021 08:11:22
: 34 Y
Location Reporting Date : 24-08-2021 15:50:28
: Life Medical Diagnostics-Abu Dhabi
Ref. By Dr. Verified Date : 24-08-2021 15:50:28
: Moleculer Biology
Test Result Reference Range Methodology

COVID-19 by RT-PCR Negative Negative ORF1 and N genes

detection by RT-PCR
(Euroimmune/EUROReal
Time assay)
-- Specimen type: Nasopharyngeal Swab on Viral Transport Media.

-- Test Methodology:
COVID-19 Detection Kit is an in vitro diagnostic assay intended for Real-time PCR based detection of new SARS-CoV-2 RNA virus for
confirmation of COVID-19 disease in patients with suspect viral infection.

--Results Interpretation:
- Detected samples are reported as: "Positive".
- Not detected samples are reported as : "Negative".
- Sample reported as "inconclusive'' may contain low amount of viral RNA and should be repeated for confirmation.

--Limitations:
1.As with all diagnostic tests, a definitive clinical diagnosis should not be based on the result of a single test, but should only be made after all
clinical and laboratory findings have been evaluated. Collection of multiple specimens from the same patient may be necessary to detect the
virus.
2.A false negative result may occur if a specimen is improperly collected, transported or handled. False negative results may also occur if
amplification inhibitors are present in the specimen or if organisms present in the specimen is in a concentration below the assay's limit of
detection.
3.This test cannot rule out diseases caused by other bacterial or viral pathogens.

-- Disclaimer: This assay has been validated and its performance characteristics have been determined by Life Medical Diagnostic Centre in the
Emirate of Abudhabi; Department of Molecular Biology.

--REFERENCES:
1.Clinical Laboratory Standards Institute (CLSI), "Collection, Transport, Preparation and Storage of Specimens for Molecular Methods:
Proposed Guideline," MM13-A
2.Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19).
https://www.cdc.gov/coronavirus/2019-ncov/lab/lab biosafety-guidelines.html
End of Report

Reviewed By: Dr. Tahani Amer Approved By : Dr. Rania Bedair,MD,PhD

Lab Director Consultant Pathologist
GD19216 Final Report GD36605
Page 1 of 1
THIS IS A SYSTEM GENERATED REPORT AND DOES NOT REQUIRE PHYSICAL SIGNATURE
Printed By: Printed Date: 24/08/2021 06:48